Biomet Orthopedics

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Biomet Orthopedics sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).

10 total trials none currently recruiting 5 completed top decile by trial count

Biomet Orthopedics: 10 sponsored US clinical trials, none currently recruiting.

Biomet Orthopedics sponsors 10 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. The most-studied condition in this pipeline is Avascular Necrosis, with 1 trials.

Top-decile sponsor footprint

Biomet Orthopedics ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 0/100

5 of 10 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (50.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

10 total, page 1 of 1

TERMINATED

ExploR® Modular Radial Head Data Collection

NCT00533234
TERMINATED

I-beam and Cruciate Tibial Components Used in Total Knee Replacement

NCT00588783
COMPLETED

A Clinical Investigation of the C2a-Taper™ Acetabular System

NCT00578851
COMPLETED

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

NCT00578994
COMPLETED

A Clinical Investigation of the Taperloc® Microplasty™ Hip System

NCT00699309
TERMINATED

Total Knee Replacement With Duracon® and Vanguard™ Prostheses

NCT00588887
COMPLETED

A Clinical Investigation of the Balance® Microplasty™ Hip System

NCT00699088
TERMINATED NA

Maxim® Knee Pop-Top® Tibia vs. Regular Maxim® Knee Tibia

NCT00579059
TERMINATED NA

Total Hip Replacement With the Answer® Hip Stem and Ranawat/Burnstein® Shell Using Simplex® or Palacos® Bone Cement

NCT00588861
COMPLETED

A Clinical Investigation of the Discovery™ Elbow System

NCT00698867

Therapeutic Areas

Avascular Necrosis 1
Osteoarthritis 1

How the Biomet Orthopedics archive is shaped

10 indexed studies, none listed as recruiting (0% open); 5 completed (50%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Avascular Necrosis (1 trial), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Biomet Orthopedics: archived-pipeline peers nationwide

Peers matched on 10 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Biomet Orthopedics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share Biomet OrthopedicsAdamas PharmaceuticalsAdverum BiotechnologiesAevi Genomic Medicine, LLC, a Cerecor companyAgouron Pharmaceuticals10xBio22nd Century Group23andMe3-C Institute for Social Development
Biomet Orthopedics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Biomet Orthopedics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 10 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Biomet Orthopedics page

10 registered trials is a research-attention snapshot, not an endorsement of Biomet Orthopedics or any single study.

  • None of Biomet Orthopedics's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Avascular Necrosis is the condition Biomet Orthopedics studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Avascular Necrosis trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Biomet Orthopedics pipeline card: 10 registered trials from official public datasets.Report a data error.